×

Lbt Innovations Limited

LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. We specialise in bringing advanced medical technologies to market. Our core capabilities include artificial intelligence, image analysis and software engineering solutions that improve medical diagnostic workflows.

LBT Innovations first technology was an automated culture plate streaking system called MicroStreak. It was brought to market as the PREVI® Isola and initiated a new era in automation for clinical laboratories.

Following its success, LBT Innovations partnered with the Australian Institute of Machine Learning to develop the Automated Plate Assessment System (APAS®). This technology performs automated image capture, analysis and interpretation of culture plates delivering efficiencies to the microbiology workflow. In 2016 it became the first artificial intelligence diagnostic medical device to achieve FDA Class II clearance. The technology is currently being commercialised through LBT’s joint venture company Clever Culture Systems.

LBT Innovations is exploring opportunities to extend our platform APAS® “intelligent imaging” technology towards new applications including wound treatment, histopathology and antibiotic sensitivity screening, broadening our scope from practical laboratory processes to cutting-edge computer vision and analysis.

Spotlight Videos

Stocks of the Hour: ABx Group, LBT Innovations, NickelSearch

- by Abbey Phillipps

A snapshot of the stocks on the move, featuring ABx Group (ASX:ABX), LBT Innovations (ASX:LBT) and NickelSearch (ASX:NIS).

WATCH VIDEO
LBT Innovations (ASX:LBT) – Webinar Presentation
Stocks of the Hour: LBT Innovations, Selfwealth, Lucapa Diamond Co
All Lbt Innovations Limited Content

News

LBT Innovations (ASX:LBT) – Webinar Presentation

- by Company News

Brent Barnes - CEO and Managing Director - LBT Innovations (ASX:LBT) is a groundbreaking designer of advanced technology solutions for the medical industry. We specialise in bringing advanced medical technologies to market. Our core capabilities include artificial intelligence, image analysis and software engineering solutions that improve medical diagnostic workflows.

Read More